152 related articles for article (PubMed ID: 31486960)
21. Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation.
Palmieri M; Currò A; Tommasi A; Di Sarno L; Doddato G; Baldassarri M; Frullanti E; Giliberti AR; Fallerini C; Spinazzola A; Pinto AM; Renieri A; Vaghi M
JVS Vasc Sci; 2020; 1():176-180. PubMed ID: 34617046
[TBL] [Abstract][Full Text] [Related]
22. Endothelial cell expression of mutant Map2k1 causes vascular malformations in mice.
Smits PJ; Sudduth CL; Konczyk DJ; Cheng YS; Vivero MP; Kozakewich HPW; Warman ML; Greene AK
Angiogenesis; 2023 Feb; 26(1):97-105. PubMed ID: 35972708
[TBL] [Abstract][Full Text] [Related]
23.
Revencu N; Fastre E; Ravoet M; Helaers R; Brouillard P; Bisdorff-Bresson A; Chung CWT; Gerard M; Dvorakova V; Irvine AD; Boon LM; Vikkula M
J Med Genet; 2020 Jan; 57(1):48-52. PubMed ID: 31300548
[TBL] [Abstract][Full Text] [Related]
24. Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy.
Edwards EA; Phelps AS; Cooke D; Frieden IJ; Zapala MA; Fullerton HJ; Shimano KA
Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32859736
[TBL] [Abstract][Full Text] [Related]
25. Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.
Greene AK; Goss JA
Plast Reconstr Surg; 2018 May; 141(5):709e-717e. PubMed ID: 29697621
[TBL] [Abstract][Full Text] [Related]
26. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
27. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
28. Genetic Profile of Arteriovenous Anomalies of the Head and Neck: Implications in Progression and Therapeutic Approaches.
Pampín Martínez MM; Rodríguez-Laguna L; Gómez García E; Cebrián Carretero JL; González Otero T; López Gutiérrez JC
J Pediatr Surg; 2023 Oct; 58(10):2043-2049. PubMed ID: 36868957
[TBL] [Abstract][Full Text] [Related]
29. Intramuscular capillary-type hemangioma: Diagnosis, treatment, and outcomes. A French multicentric retrospective study of 66 cases.
Orly J; Bisdorff A; Fraissenon A; Joly A; Boulouis G; Guibaud L; Tavernier E; Mallet S; Marcelin C; Miquel J; Martin L; Droitcourt C; Gusdorf L; Abasq C; Dadban A; Chiaverini C; Vabres P; Herbreteau D; Boccara O; Wassef M; Maruani A
Eur J Radiol; 2023 Aug; 165():110962. PubMed ID: 37423018
[TBL] [Abstract][Full Text] [Related]
30. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
31. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
Ako S; Nouso K; Kinugasa H; Dohi C; Matushita H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H; Okada H
Pancreatology; 2017; 17(2):285-290. PubMed ID: 28139399
[TBL] [Abstract][Full Text] [Related]
32. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth.
Couto JA; Ayturk UM; Konczyk DJ; Goss JA; Huang AY; Hann S; Reeve JL; Liang MG; Bischoff J; Warman ML; Greene AK
Angiogenesis; 2017 Aug; 20(3):303-306. PubMed ID: 28120216
[TBL] [Abstract][Full Text] [Related]
33. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Fish JE; Radovanovic I
N Engl J Med; 2018 Apr; 378(16):1561-1562. PubMed ID: 29669234
[No Abstract] [Full Text] [Related]
34. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.
Al-Olabi L; Polubothu S; Dowsett K; Andrews KA; Stadnik P; Joseph AP; Knox R; Pittman A; Clark G; Baird W; Bulstrode N; Glover M; Gordon K; Hargrave D; Huson SM; Jacques TS; James G; Kondolf H; Kangesu L; Keppler-Noreuil KM; Khan A; Lindhurst MJ; Lipson M; Mansour S; O'Hara J; Mahon C; Mosica A; Moss C; Murthy A; Ong J; Parker VE; Rivière JB; Sapp JC; Sebire NJ; Shah R; Sivakumar B; Thomas A; Virasami A; Waelchli R; Zeng Z; Biesecker LG; Barnacle A; Topf M; Semple RK; Patton EE; Kinsler VA
J Clin Invest; 2018 Apr; 128(4):1496-1508. PubMed ID: 29461977
[TBL] [Abstract][Full Text] [Related]
35. Capillary malformation-arteriovenous malformation: a clinical review of 45 patients.
Larralde M; Abad ME; Luna PC; Hoffner MV
Int J Dermatol; 2014 Apr; 53(4):458-61. PubMed ID: 24168113
[TBL] [Abstract][Full Text] [Related]
36. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
Amyere M; Revencu N; Helaers R; Pairet E; Baselga E; Cordisco M; Chung W; Dubois J; Lacour JP; Martorell L; Mazereeuw-Hautier J; Pyeritz RE; Amor DJ; Bisdorff A; Blei F; Bombei H; Dompmartin A; Brooks D; Dupont J; González-Enseñat MA; Frieden I; Gérard M; Kvarnung M; Hanson-Kahn AK; Hudgins L; Léauté-Labrèze C; McCuaig C; Metry D; Parent P; Paul C; Petit F; Phan A; Quere I; Salhi A; Turner A; Vabres P; Vicente A; Wargon O; Watanabe S; Weibel L; Wilson A; Willing M; Mulliken JB; Boon LM; Vikkula M
Circulation; 2017 Sep; 136(11):1037-1048. PubMed ID: 28687708
[TBL] [Abstract][Full Text] [Related]
37. KRAS Activating Signaling Triggers Arteriovenous Malformations.
Cheng F; Nussinov R
Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
[TBL] [Abstract][Full Text] [Related]
38. Etiology and Genetics of Congenital Vascular Lesions.
Queisser A; Boon LM; Vikkula M
Otolaryngol Clin North Am; 2018 Feb; 51(1):41-53. PubMed ID: 29217067
[TBL] [Abstract][Full Text] [Related]
39. Mosaic RASopathy due to KRAS variant G12D with segmental overgrowth and associated peripheral vascular malformations.
Schmidt VF; Wieland I; Wohlgemuth WA; Ricke J; Wildgruber M; Zenker M
Am J Med Genet A; 2021 Oct; 185(10):3122-3128. PubMed ID: 34114335
[TBL] [Abstract][Full Text] [Related]
40. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks.
Soon K; Li M; Wu R; Zhou A; Khosraviani N; Turner WD; Wythe JD; Fish JE; Nunes SS
Biomaterials; 2022 Sep; 288():121729. PubMed ID: 35999080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
